For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

Every year, about 50,000 women in the US are diagnosed with ductal carcinoma in situ, or DCIS, where the cells that line milk ...

The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage zero ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer.

WASHINGTON (dpa-AFX) - According to the American Cancer Society, every year over 50,000 women suffer from ductal carcinoma in situ or DCIS, often known as 'zero-stage breast cancer' or 'precancer'.

An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...

A "watch-and-wait" strategy might be the best option for some women with early-stage, low-risk breast cancer. According to ...

Some physicians who were not involved in the research cautioned that the study period was too short to draw firm conclusions, The Wall Street Journal reported. Researchers acknowledged longer-term ...

When a woman learns she has breast cancer, her reaction is often: take it out. Now doctors say that might not always be ...

A new clinical trial offers hope for women diagnosed with ductal carcinoma in situ (DCIS), indicating that surgery may not be essential. The trial, conducted on 957 women, revealed that those in ...